MKI67 and neoplasm: Only cisplatin treatment significantly decreases tumor tissue level of Ki-67 as a cellular marker of proliferation in ESC injected mice whereas Sal-B failed to provide a similar effect of cisplatin in ESC injected mice (Figure 5B).